---
$id: https://graph.org.ai/products/commodity/51111610
$type: Product
source: UNSPSC
code: "51111610"
title: "Methotrexate"
class: "51111600"
classTitle: "Antimetabolites"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Methotrexate

**UNSPSC Code**: 51111610
**Class**: [Antimetabolites](Antimetabolites.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a folate antagonist and dihydrofolate reductase inhibitor with the molecular formula C20H22N8O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier YL5FZ2Y5U1, chemically known as poly(imino((1s)-1-carboxy-4-oxo-1,4-butanediyl)), alpha-(4-(((2,4-diamino-6-pteridinyl)methyl)methylamino)benzoyl)-omega-hydroxy- but generally known as methotrexate, which bears US NIH Compound Identifier 4112. European Medicines Agency schedules Methotrexate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08856MIG. The term METHOTREXATE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 16, No. 3 1962, List 4). World Health Organization schedules methotrexate in its Anatomical Therapeutic Chemical (ATC) Classification. METHOTREXATE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule methotrexate under HS 29335995 and SITC 51576. As of Q4 2014, METHOTREXATE remains the US FDA Preferred Term for this commodity. Methotrexate bears US NLM identifiers UMLS ID C0025677 and NCI Concept Code C642. SMILES: OC(=O)C(NC(=O)C1CCC(N(CC2NC3C(NC2)NC(NC3N)N)C)CC1)CCC(=O)O.

